TEVA PHARMACEUTICAL FIN LLC - DBCV 0.250% 2/0

CUSIP: 88163VAE9

Q4 2017 13F Holders as of 31 Dec 2017

Type / Class
Debt / DBCV 0.250% 2/0
Market price (% of par)
88.25%
Total 13F principal
$413,202,564
Principal change
-$39,854,582
Total reported market value
$363,891,303
Number of holders
58
Value change
-$36,272,462
Number of buys
24
Number of sells
21

Quarterly Holders Quick Answers

What is CUSIP 88163VAE9?
CUSIP 88163VAE9 identifies 88163VAE9 - TEVA PHARMACEUTICAL FIN LLC - DBCV 0.250% 2/0 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of TEVA PHARMACEUTICAL FIN LLC - DBCV 0.250% 2/0 as of Q4 2017

As of 31 Dec 2017, TEVA PHARMACEUTICAL FIN LLC - DBCV 0.250% 2/0 was held by 58 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $413,202,564 in principal (par value) of the bond. The largest 10 bondholders included PRUDENTIAL PLC, Allianz Asset Management GmbH, AXA, INCOME RESEARCH & MANAGEMENT, WELLS FARGO & COMPANY/MN, RIVERHEAD CAPITAL MANAGEMENT LLC, Southpaw Asset Management LP, ARISTEIA CAPITAL LLC, PICTET ASSET MANAGEMENT LTD, and Invesco Ltd.. This page lists 58 institutional bondholders reporting positions for the Q4 2017 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.